Considering Heroin-Assisted Treatment and Supervised Consumption Sites in the U.S.

Quarterly Insights from the RAND Drug Policy Research Center

Join RAND on Facebook Follow RAND on Twitter

Quarterly insights from the RAND Drug Policy Research Center

Dec 2018

Kits of supplies containing syringes, bandaids, and antiseptic pads in a safe injection site called Quai 9 near Geneva main train station, Switzerland, October 14, 2010, photo by Denis Balibouse/Reuters

Considering Heroin-Assisted Treatment and Supervised Consumption Sites in the U.S.

Given the severity of the opioid crisis, it is important to evaluate tools and approaches that could reduce its impact, even those that may be controversial. Researchers examine two options for addressing opioid-related harms that are implemented in other countries but not in the U.S.: heroin-assisted treatment (HAT) and supervised consumption sites (SCS). Read more »

Doctor and patient discussing medication, photo by JGI/Tom Grill/Getty Images

Photo by JGI/Tom Grill/Getty Images

In Opioid Policy, One Size Does Not Fit All

To solve America's opioid crisis, policymakers will need to view the epidemic as an “ecosystem,” where policies that target only one part of the problem can have unintended consequences.

Read more »

Marijuana buds and their degree of potency are shown in a medical marijuana dispensary in Oakland, California, June 30, 2010, photo by Robert Galbraith/Reuters

Photo by Robert Galbraith/Reuters

Navigating Cannabis Legalization 2.0

As the next round of states debate cannabis legalization, they would do well to contemplate allowing state governments to control the wholesale prices and linking the price of cannabis to its potency.

Read more »

Katherine E. Watkins was commended for her work on helping to improve access to opioid addiction treatment.

Improving Access to Opioid Addiction Treatment

Treatment for opioid addiction and other substance use disorders often exists apart from primary care. It's also difficult to access and under-resourced. In response to these challenges, RAND's Katherine Watkins developed an innovative approach to addiction treatment through primary care settings.

Watch the Video »

Trending Research

Patient Predictors of Substance Use Disorder Treatment Initiation in Primary Care

Supply-Side Drug Policy in the Presence of Substitutes: Evidence from the Introduction of Abuse-Deterrent Opioids

DPRC in the News

U.S.-China Fentanyl Pact Is Not Expected to Produce Immediate Results

The Washington Post

Why Amsterdam Is Jealous of America's Growing Weed Industry


Fentanyl smuggled from China is killing thousands of Americans

Los Angeles Times

Nearly 30% of All Opioid Prescriptions Lack Medical Explanation



Beau Kilmer

Beau Kilmer

Codirector, RAND Drug Policy Research Center

Rosalie Liccardo Pacula

Rosalie Liccardo Pacula

Codirector, RAND Drug Policy Research Center

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis.

Follow RAND

Privacy statement

RAND Corporation

RAND Corporation. 1776 Main Street, Santa Monica, CA 90401-3208.
RAND® is a registered trademark.